As widely expected in the industry, Göran Ando has been appointed CEO of Slough, UK-based Celltech, replacing Peter Fellner, who will serve as the company’s chairman. Ando joins the company from Pharmacia, which was recently acquired by Pfizer, where he was president of R&D and an executive vice president. Previously, he was R&D director for Glaxo Group Research. He also held positions at Astra Research Centre, Bristol-Myers International Group, and Pfizer.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.